Protein Deacetylase CobB Interplays with c-di-GMP

Zhaowei Xu, Hainan Zhang, Xingrun Zhang, Chengxi Liu, He‐wei Jiang, Fanlin Wu, Lili Qian, Daniel M. Czajkowsky, Shujuan Guo, Lijun Bi, Shihua Wang, Haitao Li, Minjia Tan, Lei Feng, Jingli Hou, Sheng‐ce TaobioRxiv 2018 · DOI

TL;DR

This paper reveals a novel negative feedback loop in bacteria where the second messenger c-di-GMP directly inhibits the protein deacetylase CobB. This inhibition, in turn, affects acetyl-CoA metabolism and the activity of YdeH, a key enzyme in c-di-GMP production, highlighting a sophisticated regulatory mechanism.

What Problem Does This Paper Address?

Bacteria utilize cyclic diguanosine monophosphate (c-di-GMP) as a crucial second messenger to regulate a wide array of cellular processes, including motility, biofilm formation, and virulence. However, the precise mechanisms by which c-di-GMP levels are controlled and how it interacts with other cellular components are still being uncovered. CobB, a well-known deacetylase, plays roles in energy metabolism and other functions, but its direct connection to c-di-GMP signaling was unclear. This study aims to elucidate how c-di-GMP interacts with CobB and to understand the functional consequences of this interaction, particularly in the context of c-di-GMP production and its downstream effects.

Methods

The researchers employed a multi-pronged approach:

  • E. coli Proteome Microarray: This high-throughput technique was used to screen for proteins that bind to c-di-GMP, identifying CobB as a strong binder.
  • Biochemical Assays:
    • Streptavidin Blotting: Used to validate the binding of c-di-GMP to CobB.
  • Isothermal Titration Calorimetry (ITC) and Microscale Thermophoresis (MST): These methods were used to quantify the binding affinity (Kd) between c-di-GMP and CobB.
  • Deacetylation Assays: Assessed CobB's activity on known substrates (Acs, CheY, NhoA) in the presence and absence of c-di-GMP to determine if c-di-GMP inhibits CobB's deacetylase function.
  • Enzyme Kinetics: Measured the catalytic rate of CobB deacetylation in the presence of varying c-di-GMP concentrations to characterize the inhibition mechanism.
  • Mutagenesis Studies: Specific residues in CobB (R8, R17, E21) were mutated to alanine to identify those critical for c-di-GMP binding.
  • In Vivo Studies:
    • E. coli Strains: Utilized strains with altered c-di-GMP levels (overexpressing YdeH or a dysfunctional YdeH mutant) and CobB-deficient strains to study the effects of c-di-GMP on CobB activity and vice versa.
  • Growth Curve Analysis: Monitored bacterial growth under different conditions to assess the physiological impact of the observed molecular interactions.
  • Stable Isotope Labeling with Amino acids in Cell culture (SILAC) coupled with Mass Spectrometry (MS): Used to quantitatively compare protein acetylation levels in different E. coli strains, revealing global effects of c-di-GMP on CobB-dependent deacetylation.
  • Mass Spectrometry (MS): Employed for in-depth analysis of acetylation sites on YdeH and to identify sites deacetylated by CobB.
  • Structural Analysis: Investigated the potential structural impact of acetylation on YdeH.

Datasets

  • E. coli Proteome Microarray Data: Raw data published in the Protein Microarray Database (www.proteinarray.cn) with accession number PMDE271.
  • SILAC MS Proteomics Raw Data: Deposited to the ProteomeXchange Consortium via the PRIDE partner repository with dataset identifier PXD007616.
  • Mass Spectrometry Raw Data for Deacetylation Site Identification: Submitted to PRIDE with project accession PXD008113.

Key Insights and Ideas

  • c-di-GMP Directly Binds and Inhibits CobB: This is a significant finding, establishing a direct molecular link between the second messenger and a key deacetylase. The binding is specific, with c-di-GMP showing much stronger affinity than cGMP or c-di-AMP.
  • A Novel Negative Feedback Loop: The paper proposes a sophisticated regulatory circuit: c-di-GMP binds to CobB, inhibiting its activity. CobB normally deacetylates YdeH, a c-di-GMP producing enzyme. By inhibiting CobB, c-di-GMP indirectly leads to increased YdeH activity and thus more c-di-GMP production, creating a feedback loop.
  • CobB's Role in YdeH Stability and Activity: CobB deacetylation of YdeH at lysine 4 (K4) is crucial for YdeH's stability and its diguanylate cyclase (DGC) activity. Acetylation of YdeH appears to lead to aggregation and reduced solubility.
  • Metabolic Implications: The inhibition of CobB by c-di-GMP affects acetyl-CoA levels, a central component of energy metabolism. This suggests c-di-GMP can influence bacterial energy status through this regulatory axis.
  • Conserved Mechanism: The binding and inhibitory effects of c-di-GMP on CobB appear to be conserved across various prokaryotes, suggesting a fundamental regulatory mechanism.

Key Results

  • c-di-GMP binds to CobB with a Kd of 21.6 µM (ITC) and 22.7 ± 1.63 µM (MST).
  • c-di-GMP noncompetitively inhibits CobB's deacetylase activity with a Ki of 32.27 µM.
  • Residues R8, R17, and E21 in CobB's N-terminal domain are essential for c-di-GMP binding but not for catalytic activity.
  • CobB effectively deacetylates YdeH at K4, enhancing YdeH's stability and DGC activity.
  • Overexpression of YdeH leads to a 36% increase in c-di-GMP levels in WT cells compared to CobB-deficient cells.
  • SILAC-MS analysis revealed that c-di-GMP globally affects CobB-dependent deacetylation in vivo.

Limitations and Future Work

  • In Vitro vs. In Vivo Affinity: The measured Kd values for c-di-GMP binding to CobB in vitro are higher than the typical micromolar concentrations of c-di-GMP observed in vivo. The authors suggest that this discrepancy might be due to unidentified molecular factors in vivo or the spatially uneven distribution of c-di-GMP within the crowded bacterial cytoplasm, where local concentrations could be much higher.
  • Mechanism of YdeH Regulation: While the study identifies K4 as a critical site for YdeH acetylation and its impact on stability and activity, the precise structural mechanism by which acetylation affects YdeH's conformation and dimerization requires further detailed investigation.
  • Broader Implications: The authors suggest that since CobB is conserved across prokaryotes and even has homologs in eukaryotes (sirtuins), c-di-GMP might also interact with human sirtuins, potentially playing roles in various biological processes, including host-pathogen interactions. This opens avenues for exploring c-di-GMP's influence beyond bacterial systems.
  • Future Functional Studies: The established negative feedback loop provides a framework for future research into the intricate regulation of c-di-GMP levels and CobB-based protein acetylation.

Summary updated

Abstract

Abstract As a ubiquitous bacterial secondary messenger, c-di-GMP plays key regulatory roles in processes such as bacterial motility and transcription regulation. CobB is the Sir2 family protein deacetylase that controls energy metabolism, chemotaxis and DNA supercoiling in many bacteria. Using an E.coli proteome microarray, we found that c-di-GMP strongly binds to CobB. Protein deacetylation assays showed that c-di-GMP inhibits CobB activity and thereby modulates the biogenesis of acetyl-CoA. Through mutagenesis studies, residues R8, R17 and E21 of CobB were shown to be required for c-di-GMP binding. Next, we found that CobB is an effective deacetylase of YdeH, a major diguanylate cyclase (DGC) of E.coli that is endogenously acetylated. Mass spectrometry analysis identified YdeH K4 as the major site of acetylation, and it could be deacetylated by CobB. Interestingly, deacetylation of YdeH enhances its stability and cyclase activity in c-di-GMP production. Thus, our work establishes a novel negative feedback loop linking c-di-GMP biogenesis and CobB-mediated protein deacetylation.
BibTeX
@misc{xu2018protein,
  author = {Zhaowei Xu and Hainan Zhang and Xingrun Zhang and Chengxi Liu and He‐wei Jiang and Fanlin Wu and Lili Qian and Daniel M. Czajkowsky and Shujuan Guo and Lijun Bi and Shihua Wang and Haitao Li and Minjia Tan and Lei Feng and Jingli Hou and Sheng‐ce Tao},
  title = {{Protein Deacetylase CobB Interplays with c-di-GMP}},
  year = {2018},
  doi = {10.1101/362293},
  howpublished = {bioRxiv},
}
Figure